Protective Effect of Qiliqiangxin against Doxorubicin-Induced Cardiomyopathy by Suppressing Excessive Autophagy and Apoptosis

• Main Authors: Yating Qin (Author), Chao Lv (Author), Xinxin Zhang (Author), Weibin Ruan (Author), Xiangyu Xu (Author), Chen Chen (Author), Xiaoning Wan (Author), Xinyun Ji (Author), Juan Zhou (Author), Li Lu (Author), Xiaomei Guo (Author)
• Format: Book
• Published: Hindawi-Wiley, 2022-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background. Doxorubicin (DOX) is one of the most potent and widely prescribed antitumor agents; however, its clinical use is limited by cardiac side effects. In this study, we aimed to clarify the protective effects of Qiliqiangxin (QL), a traditional Chinese medicine formulation, on DOX-induced car...